High-level aminoglycoside-resistant Enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 6, 1997, Pages 628-630

  Antony, Suresh J ^a,c   Ladner, Jennifer ^b   Stratton, Charles W ^b   Raudales, Fernando ^b   Dummer, Stephen J ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; IMIPENEM; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN;

EID: 0031432534     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035908     Document Type: Article

References (12)

1. Antony SJ, Matheren P, Stratton CW. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci. Scand J Infect Dis 1995; 27: 401-3.
2. Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug resistant enterococcal experimental endocarditis with combinations of cell wall active agents. J Infect Dis 1996; 173: 909-13.
3. Megan DW. Enterococcal endocarditis. Clin Infect Dis 1992; 15: 63-71.
4. Moellering RC. The enterococci: an enigma and a continuing challenge. Eur J Clin Microbiol Infect Dis 1990; 9: 73-4.
5. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin susceptible and streptomycin resistant enterococcal endocarditis. Ann Intern Med 1984; 100: 816-23.
6. Koenig MG, Kaye D. Enterococcal endocarditis: report of 19 cases with long-term follow-up data. N Engl J Med 1961; 264: 257-64.
7. Wilkowske CJ. Enterococcal endocarditis. Mayo Clin Proc 1982; 57: 101-5.
8. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in Laboratory Medicine, 3rd ed. Baltimore: Williams & Williams, 1991: 432.
9. Eliopoulas G. Aminoglycoside resistant enterococcal endocarditis. Infect Dis Clin North Am 1993; 7: 117-33.
10. Bisno AL, Dismukes WE, Durack DT. Antimicrobial therapy of infective endocarditis due to viridans streptococcal, enterococci and staphylococci. JAMA 1989; 261: 1471.
11. Eliopoulos GM. Enterococcal endocarditis. In: Kaye D, editor. Infective endocarditis, 2nd ed. New York: Raven Press, 1992: 209.
12. Auckenthaler GM, Wilson DR, Wright AJ, Washington AJ, Durack DT, Geraci JE. Lack of an in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococcus. Antimicrob Agents Chemother 1982; 22: 448-52.